News & Updates

Machine learning predicts AF in heart failure patients
Machine learning predicts AF in heart failure patients
10 Nov 2023
Rosuvastatin on par with atorvastatin in CAD
Rosuvastatin on par with atorvastatin in CAD
06 Nov 2023 byStephen Padilla

Rosuvastatin is as effective as atorvastatin for the composite outcome of all-cause death, myocardial infarction (MI), stroke, or any coronary revascularization at 3 years in adults with coronary artery disease (CAD), according to the secondary analysis of the LODESTAR trial.

Rosuvastatin on par with atorvastatin in CAD
06 Nov 2023
Cefazolin beneficial in infective endocarditis caused by methicillin-susceptible S aureus
Cefazolin beneficial in infective endocarditis caused by methicillin-susceptible S aureus
06 Nov 2023